Ursodeoxycholic acid in the prevention of gallstones in patients subjected to Roux-en-Y gastric bypass1.

Francisco Heine Ferreira MachadoHeladio Feitosa de Castro FilhoRodrigo Feitosa de Albuquerque Lima BabadopulosHermano Alexandre Rocha LimaJosé Lima de Carvalho RochaManoel Odorico de Moraes Filho

Published in: Acta cirurgica brasileira (2019)

The results demonstrated that patients who did not use UDCA showed a 24.4-fold greater probability of developing cholelithiasis.

Keyphrases

roux en y gastric bypass
end stage renal disease
weight loss
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
obese patients